Preprints
Le Ngoc C; Chai H; Airey G; Das T; Jennings D; Xu M; Flower B; Marjaneh MM; McCabe L; Le Manh H; Nguyen Van Vinh C; Dang Trong T; Pham Ngoc T; Vu Thi Thu H; Thwaites GE; van Doorn HR; Day J; Kestelyn E; Le Van T; Rahman M; Pett S; Barnes E; Walker AS; Cooke GS; Ansari MA, 2026, Unraveling HCV Diversity and Resistance in Viet Nam: Implications for Treatment, http://dx.doi.org/10.64898/2026.03.14.26348368
Lee MJ; Cherrill L-R; Zacharopoulou P; Collins S; Fumagalli M; Falaschetti E; Altaf M; Tipoe T; Godakandaarachi P; Fox J; Uriel A; Clarke A; Loes SK-D; Pett S; Boffito M; Whitlock G; Søgaard OS; Ring K; Mangawa I; Gohil J; Elliott T; Nielsen H; Gunst JD; Orkin C; Sutherland R; Hamzah L; Cicconi P; Taylor GP; Ujetz J; Jahan I; Brown H; Robinson N; Fletcher S; Box H; Seaton KE; Tomaras G; Ackerman ME; Weiner JA; Kaczynska A; Bittar C; Horowitz J; Nussenzweig MC; Caskey M; Frater J; Fidler S, 2026, Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial., http://dx.doi.org/10.64898/2026.02.04.25342277
Altaf M; Nel C; Tipoe T; Edgar J; Zacharopoulou P; Srai D; Knight C; Lee M; Cherrill L-R; Falaschetti E; Ogbe A; Fletcher S; Box H; Elliott T; Kinloch S; Fox J; Clarke A; Pett S; Collins S; Balachandran M; Topping K; Terry L; Seaton K; Tomaras G; Uriel A; Orkin C; Ring K; Whitlock G; Boffito M; Sutherland R; Søgaard OS; Gunst JD; Brown H; Robinson N; Lindegard G; Goulder P; Taylor G; Caskey M; Nussenzweig M; Fidler S; Frater J; RIO Study Team , 2026, T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy., http://dx.doi.org/10.64898/2026.02.02.26345374
Fumagalli MJ; Kaczynska A; Allombert M; Lopes-Ribeiro Á; de Oliveira Silva M; Hernandez BJ; Lavine C; Espinosa SM; Brown H; Box H; Falaschetti E; Cherrill L-R; Elliott T; Lee M; Fox J; Pett S; Clarke A; Uriel A; Sogaard O; Sutherland R; Boffito M; Kinloch-Loes S; Orkin C; Collins S; Zacharopoulou P; Robison N; Bittar C; Oliveira T; Gazumyan A; Jankovic M; Seaman MS; Frater J; Caskey M; Fidler S; Nussenzweig MC, 2025, Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial., http://dx.doi.org/10.1101/2025.11.03.25339415
Michael B; Wood G; Sargent B; Ahmad Z-U-A; Tharmaratnam K; Dunai C; Egbe F; Martin N; Facer B; Pendered S; Rogers H; Hübel C; Wamelen DV; Bethlehem R; Giunchiglia V; Hellyer P; Trender W; Kalsi G; Needham E; Easton A; Jackson T; Cunningham C; Upthegrove R; Pollak T; Hotopf M; Solomon T; Pett S; Shaw P; Wood N; Harrison N; Miller K; Jezzard P; Williams G; Duff E; Williams S; Zelaya F; Smith S; Keller S; Broome M; Kingston N; Husain M; Vincent A; Bradley J; Chinnery P; Menon D; Aggleton J; Nicholson T; Taylor J-P; David A; Carson A; Bullmore E; Breen G; Hampshire A; Paddick S-M; corsortium COVID-CNS; Leek C, 2024, Post-COVID cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction: national prospective study, http://dx.doi.org/10.21203/rs.3.rs-3818580/v1
Griffiths J; Fox L; Williamson PPR; Adshead F; Salman PRA-S; Anderson C; Bedson E; Bliss PJ; Boshoff A; Chen X; Cranley D; Doran PP; Gamble PC; Hood PK; McGregor N; McNamara C; Midha E; Moore K; Perkins AM; Pett S; Sydes PMR, 2023, Quantifying the carbon footprint of clinical trials: guidance development and pilot study, http://dx.doi.org/10.21203/rs.3.rs-2936937/v1
Flower B; Hung LM; McCabe L; Ansari MA; Le Ngoc C; Vo Thi T; Vu Thi Kim H; Nguyen Thi Ngoc P; Phuong LT; Quang VM; Trong TD; Le Thi T; Bao TN; Kingsley C; Smith D; Hoglund RM; Tarning J; Kestelyn E; Pett SL; van Doorn R; van Nuil JI; Turner H; Thwaites G; Barnes E; Rahman M; Walker AS; Day J; Van Vinh Chau N; Cooke GS, 2022, Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for Hepatitis C: a single arm mechanistic pilot study, http://dx.doi.org/10.1101/2022.08.15.22278752
Scott K; Chappell E; Mostafa A; Volokha A; Najmi N; Ebeid F; Posokhova S; Sikandar R; Vasylyev M; Zulfiqar S; Kaminskyi V; Pett S; Malyuta R; Karpus R; Ayman Y; Ahmed RHM; Hamid S; El-Sayed MH; Gibb D; Judd A; Collins IJ, 2021, Acceptability of Hepatitis C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan and Ukraine, http://dx.doi.org/10.1101/2021.09.29.21264171
Murray DD; Babiker AG; Baker JV; Barkauskas CE; Brown SM; Chang CC; Davey VJ; Gelijns AC; Ginde AA; Grund B; Higgs E; Hudson F; Kan VL; Lane HC; Murray TA; Paredes R; Parmar MKB; Pett S; Phillips AN; Polizzotto MN; Reilly C; Sandkovsky U; Sharma S; Teitelbaum M; Thompson BT; Young BE; Neaton JD; Lundgren JD, 2021, Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)., http://dx.doi.org/10.1101/2020.11.08.20227876
Cooke GS; Pett S; McCabe L; Jones C; Gilson R; Verma S; Ryder SD; Collier JD; Barclay ST; Ala A; Bhagani S; Nelson M; Ch’Ng C; Stone B; Wiselka M; Forton D; McPherson S; Halford R; Nguyen D; Smith D; Ansari A; Dennis E; Hudson F; Barnes EJ; Walker AS, 2021, Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C, http://dx.doi.org/10.1101/2021.01.22.21250208
McCabe L; White IR; Chau NVV; Barnes E; Pett SL; Cooke GS; Walker AS, 2019, The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct acting antiviral Hepatitis C treatment strategies in Vietnam, http://dx.doi.org/10.48550/arxiv.1911.02272
Butler M; Tamborska A; Wood G; Ellul M; Thomas RH; Galea I; Pett S; Solomon T; Pollak T; Michael B; Nicholson T, Defining Causality in Neurological & Neuropsychiatric COVID-19 Vaccine Complications: What Have We Learnt from Current and Previous Vaccination Campaigns?, http://dx.doi.org/10.2139/ssrn.3823441
Grundmann A; Wu C-H; Hardwick M; Baillie JK; Openshaw P; Semple MG; Böhning D; Pett S; Michael B; Thomas RH; Galea I, Impact of Dexamethasone and Remdesivir on Neurological Complications during COVID-19, http://dx.doi.org/10.2139/ssrn.4065552
Davey RT; Fernandez-Cruz E; Markowitz N; Pett S; Babiker A; Wentworth D; Khurana S; Engen N; Gordin F; Jain MK; Kan V; Polizzotto MN; Riska P; Ruxrungtham K; Temesgen Z; Lundgren J; Beigel J; Lane HC; Neaton JD, Influenza Immunoglobulin for Adults Hospitalized with Influenza, http://dx.doi.org/10.2139/ssrn.3365086
Ray STJ; Abdel-Mannan O; Sa M; Fuller C; Wood GK; Psyden K; Yoong M; Ramas S; McCullagh H; Scott D; McMahon M; Thomas N; Taylor M; Vollmer B; Illingworth M; McCrea N; Davies V; Whitehouse W; Zuberi S; Guthrie K; Wassmer E; Shah N; Baker MR; Tiwary S; Petropoulos C; Vlachou V; Kinali M; Tan HJ; Varma U; Ram D; Avula S; Breen G; Enright N; Hassell J; Ross Russell AL; Kumar R; Mulholland RE; Pett S; Galea I; Thomas RH; Lim M; Hacohen Y; Solomon T; Griffiths MJ; Michael BD; Kneen R; Group CS, Neurological and Psychiatric Manifestations of COVID-19 in UK Children: A Prospective National Cohort Study, http://dx.doi.org/10.2139/ssrn.3844784
Grundmann A; Hardwick M; Wu C-H; Semple MG; Böhning D; Pett S; Michael BD; Thomas RH; Galea I, Prevention of Neurological Complications During COVID-19: Protocol for a Retrospective Analysis of the ISARIC4C National Cohort, http://dx.doi.org/10.2139/ssrn.4037376
Ross Russell A; Hardwick M; Jeyanantham A; White L; Deb S; Burnside G; Joy H; Smith C; Pollak T; Nicholson T; Davies NWS; Manji H; Easton A; Ray S; Zandi M; Coles JP; Menon D; Varatharaj A; McCausland B; Ellul M; Thomas N; Breen G; Keddie S; Lunn M; Al-Shahi Salman R; Carson A; Joyce E; Turner MR; Benjamin L; Solomon T; Kneen R; Pett S; Thomas RH; Michael B; Galea I, Spectrum, Risk Factors, and Outcomes of Neurological and Psychiatric Complications of COVID-19: A UK-Wide Cross-Sectional Surveillance Study, http://dx.doi.org/10.2139/ssrn.3767901
Varatharaj A; Thomas N; Ellul M; Davies NWS; Pollak T; Tenorio EL; Sultan M; Easton A; Breen G; Zandi M; Coles JP; Manji H; Al-Shahi Salman R; Menon D; Nicholson T; Benjamin L; Carson A; Smith C; Turner MR; Solomon T; Kneen R; Pett S; Galea I; Thomas RH; Michael B, UK-Wide Surveillance of Neurological and Neuropsychiatric Complications of COVID-19: The First 153 Patients, http://dx.doi.org/10.2139/ssrn.3601761
Back to profile page